Specific-cohort formulations for product life extension

Geriatric dosage forms provide an opportunity to extend a product’s life cycle. Successfully developing products for geriatric populations requires nuanced formulation strategies; Mikart’s in-house regulatory team’s track record of FDA-approved geriatric formulations speaks to our executional expertise in this specialized area. Employing taste masking and palatability strategies, excipient selection, and route of administration and PK profiles, we take geriatric formulations from conceptualization to commercialization.